Barclays Initiates Coverage On CME Gr with Overweight Rating, Announces Price Target of $215
Portfolio Pulse from richadhand@benzinga.com
Barclays analyst Jeremy Campbell has initiated coverage on CME Group (NASDAQ:CME) with an Overweight rating and a price target of $215.

June 28, 2023 | 10:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has initiated coverage on CME Group with an Overweight rating and a price target of $215, which could positively impact the stock in the short term.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. An Overweight rating suggests that Barclays expects CME Group's stock to outperform the market, while a price target of $215 indicates a potential upside from the current price. This could lead to increased buying pressure, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100